CoChat

Reduced Serotonin Receptor Subtypes in a Limbic and a Neocortical Region in Autism

Open access
Oblak, Adrian, Gibbs, Terrell T., Blatt, Gene J. · 2013 · Autism Research
Cited by 97

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Autism is a behaviorally defined, neurological disorder with symptom onset before the age of 3. Abnormalities in social‐emotional behaviors are a core deficit in autism, and are characterized by impaired reciprocal–social interaction, lack of facial expressions, and the inability to recognize familiar faces. The posterior cingulate cortex (PCC) and fusiform gyrus (FG) are two regions within an extensive limbic‐cortical network that contribute to social‐emotional behaviors. Evidence indicates that changes in brains of individuals with autism begin prenatally. Serotonin (5‐HT) is one of the earliest expressed neurotransmitters, and plays an important role in synaptogenesis, neurite outgrowth, and neuronal migration. Abnormalities in 5‐HT systems have been implicated in several psychiatric disorders, including autism, as evidenced by immunology, imaging, genetics, pharmacotherapy, and neuropathology. Although information is known regarding peripheral 5‐HT in autism, there is emerging evidence that 5‐HT systems in the central nervous system, including various 5‐HT receptor subtypes and transporters, are affected in autism. The present study demonstrated significant reductions in 5‐HT 1A receptor‐binding density in superficial and deep layers of the PCC and FG, and in the density of 5‐HT 2A receptors in superficial layers of the PCC and FG. A significant reduction in the density of serotonin transporters (5‐HTT) was also found in the deep layers of the FG, but normal levels were demonstrated in both layers of the PCC and superficial layers of the FG. This study provides potential substrates for decreased 5‐HT modulation/innervation in the autism brain, and implicate two 5‐HT receptor subtypes as potential neuromarkers for novel or existing pharmacotherapies. Autism Res 2013, 6: 571–583. © 2013 International Society for Autism Research, Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/aur.1317

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 45

  1. 10.1007/BF01048241 · DOI
  2. 10.1093/brain/121.5.889 · DOI · Paper page
  3. Baio J., 2012, Prevalence of autism spectrum disorders — Autism and developmental disabilities monitoring network, 14 sites, United States, 2008, National Center on Birth Defects and Developmental Disabilities, CDC, Morbidity and Mortality Weekly Report (MMWR), Surveillance Summaries, 61, 1
  4. Brodmann K., 1909, Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues
  5. Brune C.W., 2006, 5‐HTTLPR genotype‐specific phenotype in children and adolescents with autism, The American Journal of Psychiatry, 163, 2148, 10.1176/ajp.2006.163.12.2148 · DOI · Paper page
  6. 10.1002/ana.20196 · DOI · Paper page
  7. 10.1177/1073858406290375 · DOI · Paper page
  8. 10.1177/1073858403253552 · DOI · Paper page
  9. 10.1046/j.1528-1157.2002.34101.x · doi:10.1046/j.1528-1157.2002.34101.x
  10. 10.1002/14651858.CD009043.pub2 · DOI
  11. 10.1097/00008480-199608000-00008 · DOI · Paper page
  12. 10.1016/0024-3205(93)90685-V · DOI · Paper page
  13. 10.1089/104454602760386932 · DOI · Paper page
  14. 10.1001/archgenpsychiatry.2012.513 · DOI · Paper page
  15. 10.1111/j.1469-8749.1998.tb15414.x · DOI · Paper page
  16. 10.1016/0006-8993(85)91613-0 · DOI · Paper page
  17. 10.1111/j.1469-7610.1990.tb00834.x · DOI · Paper page
  18. 10.1007/s10803-008-0604-4 · DOI
  19. 10.1016/j.neuroimage.2004.03.025 · DOI · Paper page
  20. 10.1038/sj.npp.1300627 · DOI · Paper page
  21. Hoshino Y., 1987, Clinical features of autistic children with setback course in their infancy, The Japanese Journal of Psychiatry and Neurology, 41, 237
  22. 10.1007/s10803-006-0324-6 · DOI
  23. 10.1523/JNEUROSCI.17-11-04302.1997 · DOI · Paper page
  24. 10.1176/appi.ajp.162.6.1142 · DOI · Paper page
  25. 10.1016/j.neuroimage.2004.02.014 · DOI
  26. 10.1001/archneur.62.6.946 · doi:10.1001/archneur.62.6.946
  27. 10.1176/ajp.2006.163.5.934 · DOI · Paper page
  28. 10.1097/00004703-200304000-00005 · DOI · Paper page
  29. 10.1523/JNEUROSCI.2792-11.2011 · DOI · Paper page
  30. 10.1002/aur.88 · DOI · Paper page
  31. 10.1016/j.brainres.2010.09.021 · DOI · Paper page
  32. 10.1002/aur.188 · DOI · Paper page
  33. 10.1007/s10803-011-1240-y · DOI
  34. 10.1177/002215549804601006 · DOI
  35. 10.1089/cap.2006.16.379 · DOI · Paper page
  36. 10.1007/BF02206997 · DOI
  37. 10.1089/cap.2006.16.181 · DOI · Paper page
  38. 10.1542/peds.2003-0264-F · DOI · Paper page
  39. 10.1007/s00401-009-0568-2 · DOI · Paper page
  40. 10.1111/j.1601-183X.2008.00390.x · DOI · Paper page
  41. 10.1016/j.ejphar.2005.02.051 · DOI
  42. 10.1001/archpsyc.64.6.709 · DOI · Paper page
  43. 10.1016/j.neuroimage.2010.04.262 · DOI · Paper page
  44. 10.1016/j.brainres.2009.11.057 · DOI · Paper page
  45. West L., 2006, Risperidone use in the treatment of behavioral symptoms in children with autism, Pediatric Nursing, 32, 545

Cited by

Metadata

Authors
Oblak, A., Gibbs, T. T., & Blatt, G. J.
Venue
Autism Research
Publisher
Wiley
Published
2013-07-24
Volume
6
Issue
6
Pages
571-583
ISSN
  • 1939-3792 (ISSN-L)
  • 1939-3806
OpenAlex
W1484440311
Cited by
97
References
23
FWCI
2.69
Type
journal article
Language
en
Open access
green
Funders
  • Studies to Advance Autism Research and Treatment (STAART) grant from the National Institutes of Health (U54 MH66398)
  • The Nancy Lurie Marks Foundation
  • The Hussman Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.